01:52 PM EST, 01/27/2025 (MT Newswires) -- Allakos ( ALLK ) said Monday its phase 1 trial of AK006 in chronic spontaneous urticaria failed to demonstrate therapeutic efficacy and that its development will be terminated immediately.

Shares slumped 79% as intraday trading volume rose sharply to 36 million from a daily average of about 623,000.

The Marygold Companies ( MGLD ) said it priced an underwritten public offering of 2.05 million shares at $1.10 apiece, targeting gross proceeds of about $2.3 million.

Shares slumped 29% as intraday trading volume increased to over 405,000 versus a daily average of about 14,000.

Nvidia ( NVDA ) joined a share-price slump in artificial intelligence industry peers after an AI program from China, DeepSeek, raised questions about the use of computing power and the cost-effectiveness of rival platforms in the US.

Shares slid over 16%, with intraday trading volume at 561.6 million versus the stock's daily average of about 211.1 million.

Price: 0.25, Change: -0.96, Percent Change: -79.50